When considering endometrioid ovarian carcinoma patients, the mRNA expression levels of LOX, LOXL1, LOXL2, LOXL3, and LOXL4 demonstrated no relation with OS or PFS. This evidence concerns the gene LOX and ovarian endometrioid carcinoma.